About Us

Leading ALS Organizations Celebrate Introduction of ACT for ALS Reauthorization Act: Call for Swift Congressional Passage

Washington, D.C., April 8, 2026 – In support of this week’s introduction of the ACT for ALS Reauthorization Act of 2026 (H.R.8205), leading ALS advocacy organizations released the following statement calling for swift passage of the legislation:

“This week’s introduction of the ACT for ALS Reauthorization Act of 2026 is a meaningful milestone in our unified efforts to reauthorize the ACT prior to the September 30, 2026, deadline. We are incredibly grateful to Congressmen Quigley and Calvert for their leadership in introducing this bill. Congress must act swiftly to enact this critical legislation.

The ACT for ALS Act, enacted in December 2021, has resulted in meaningful and potentially life-changing impacts for the ALS and rare neurodegenerative disease communities. The National Institutes of Health (NIH) ALS Expanded Access program has funded approximately 750 community members with ALS receiving investigational new treatments and has equipped clinics across the United States with the ability to participate in ALS research. The Access for ALL in ALS Consortium (ALL ALS), funded by the NIH through the ACT for ALS, is one of the largest and most important efforts to understand and evaluate the natural history of ALS. The Public-Private Partnerships on rare neurogenerative diseases (Accelerating Medicines Partnership ® in Amyotrophic Lateral Sclerosis [AMP® ALS] Program and the Critical Path for Rare Neurodegenerative Diseases Program [C-Path RND]) have made meaningful strides in accelerating data integration, digital biomarkers, and therapeutic development, particularly for ALS, and the FDA’s Rare Neurodegenerative Disease Grants Program has funded over $20 million in research accelerating therapeutic development across the spectrum of rare neurodegenerative diseases.

The legislation also makes refinements to ACT for ALS programs in response to report findings to ensure their continued success in the years ahead. All these important advancements may cease to exist unless Congress passes the ACT for ALS Reauthorization Act.

Congress must act quickly; the ALS community cannot wait.”

Signed:

• ALS Arizona
• ALS Association
• ALS Hope Foundation
• ALS One
• ALS Network
• ALS of Nevada
• ALS New Mexico
• ALS Northwest
• ALS United
• ALS United Connecticut
• ALS United of Georgia
• ALS United Greater New York
• ALS United Illinois, Indiana, & Missouri
• ALS United Mid-Atlantic
• ALS United North Carolina
• ALS United Ohio
• ALS United Orange County
• ALS United Rhode Island
• ALS United Rocky Mountain Answer ALS
• Compassionate Care ALS
• Hop on a Cure
• I AM ALS
• Les Turner ALS Foundation
• Muscular Dystrophy Association
• Project ALS
• Target ALS